One insurtech startup CEO says that single-point startups are "contributing to fragmentation. The key is to solve problems in the marketplace for customers and carriers alike."
Paying for high-cost, breakthrough drugs is one of healthcare's abiding challenges—and tied to so many of the "pre-existing" conditions that plague the industry as it tries to innovate.
Opponents' primary argument is that covering the uninsured, while noble, fails to address healthcare's other related albatross—skyrocketing costs, including for prescription drugs—with fixed premiums and lower reimbursement rates applying further constraints.
